PL345365A1 - Salts of paroxetine - Google Patents
Salts of paroxetineInfo
- Publication number
- PL345365A1 PL345365A1 PL99345365A PL34536599A PL345365A1 PL 345365 A1 PL345365 A1 PL 345365A1 PL 99345365 A PL99345365 A PL 99345365A PL 34536599 A PL34536599 A PL 34536599A PL 345365 A1 PL345365 A1 PL 345365A1
- Authority
- PL
- Poland
- Prior art keywords
- paroxetine
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9814316.7A GB9814316D0 (en) | 1998-07-02 | 1998-07-02 | Novel compounds |
PCT/EP1999/004543 WO2000001692A1 (en) | 1998-07-02 | 1999-06-30 | Salts of paroxetine |
Publications (1)
Publication Number | Publication Date |
---|---|
PL345365A1 true PL345365A1 (en) | 2001-12-17 |
Family
ID=10834803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL99345365A PL345365A1 (en) | 1998-07-02 | 1999-06-30 | Salts of paroxetine |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1091958A1 (en) |
JP (1) | JP2002519421A (en) |
KR (1) | KR20010053337A (en) |
CN (1) | CN1314906A (en) |
AP (1) | AP2000002017A0 (en) |
AU (2) | AU4903999A (en) |
BG (1) | BG105204A (en) |
BR (1) | BR9911679A (en) |
CA (1) | CA2336470A1 (en) |
CZ (1) | CZ20004923A3 (en) |
EA (1) | EA200100098A1 (en) |
GB (1) | GB9814316D0 (en) |
HU (1) | HUP0103712A3 (en) |
ID (1) | ID27766A (en) |
IL (1) | IL140385A0 (en) |
NO (1) | NO20006547L (en) |
PL (1) | PL345365A1 (en) |
SK (1) | SK20242000A3 (en) |
TR (1) | TR200100055T2 (en) |
WO (1) | WO2000001692A1 (en) |
ZA (2) | ZA992899B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1534305T3 (en) | 2003-05-07 | 2007-02-05 | Osteologix As | Treatment of cartilage / bone disorders with water-soluble strontium salts |
SI1622630T1 (en) | 2003-05-07 | 2012-12-31 | Osteologix A/S | Strontium combinations for the prophylaxis/treatment of cartilage and/or bone conditions |
KR101165614B1 (en) | 2004-02-26 | 2012-07-18 | 오스테올로지스 에이에스 | Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions |
CA2565840A1 (en) | 2004-05-06 | 2005-11-17 | Osteologix A/S | High yield and rapid syntheses methods for producing metallo-organic salts |
KR100672184B1 (en) * | 2004-09-21 | 2007-01-19 | 주식회사종근당 | Paroxetine cholate or cholic acid derivative salts |
US9873667B2 (en) | 2006-07-27 | 2018-01-23 | Emisphere Technologies Inc. | Arylsulfanyl compounds and compositions for delivering active agents |
CN109212055B (en) * | 2018-08-19 | 2021-05-07 | 丁立平 | Gas chromatography-mass spectrometry combined method for determining four trace monohalogenated phenylacetic acids in drinking water |
CN109342633B (en) * | 2018-11-27 | 2020-10-02 | 北京市化工职业病防治院 | Method for detecting metabolites of benzene, toluene and xylene in urine |
CN111337460B (en) * | 2018-12-18 | 2021-09-17 | 中国科学院大连化学物理研究所 | High-stability Halo-tag probe and synthesis and biological application thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8430581D0 (en) * | 1984-12-04 | 1985-01-09 | Ferrosan As | Treatment |
ES2058061T3 (en) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | DERIVED FROM PIPERIDINE, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT. |
CA2206592A1 (en) * | 1996-05-30 | 1997-11-30 | Shu-Zhong Wang | Method of producing amorphous paroxetine hydrochloride |
HU221921B1 (en) * | 1996-07-08 | 2003-02-28 | Richter Gedeon Vegyészeti Gyár Rt. | N-benzyl-piperidine or tetrahydro-pyridine derivatives and processes for producing them |
WO1998056787A1 (en) * | 1997-06-10 | 1998-12-17 | Synthon B.V. | 4-Phenylpiperidine compounds |
PL342295A1 (en) * | 1998-02-06 | 2001-06-04 | Smithkline Beecham Plc | Paroxetin salts |
-
1998
- 1998-07-02 GB GBGB9814316.7A patent/GB9814316D0/en not_active Ceased
-
1999
- 1999-04-23 ZA ZA9902899A patent/ZA992899B/en unknown
- 1999-06-30 PL PL99345365A patent/PL345365A1/en not_active Application Discontinuation
- 1999-06-30 EA EA200100098A patent/EA200100098A1/en unknown
- 1999-06-30 AP APAP/P/2000/002017A patent/AP2000002017A0/en unknown
- 1999-06-30 CA CA002336470A patent/CA2336470A1/en not_active Abandoned
- 1999-06-30 JP JP2000558095A patent/JP2002519421A/en active Pending
- 1999-06-30 CN CN99810197A patent/CN1314906A/en active Pending
- 1999-06-30 ID IDW20010252A patent/ID27766A/en unknown
- 1999-06-30 HU HU0103712A patent/HUP0103712A3/en unknown
- 1999-06-30 AU AU49039/99A patent/AU4903999A/en not_active Abandoned
- 1999-06-30 KR KR1020007015100A patent/KR20010053337A/en not_active Application Discontinuation
- 1999-06-30 TR TR2001/00055T patent/TR200100055T2/en unknown
- 1999-06-30 WO PCT/EP1999/004543 patent/WO2000001692A1/en not_active Application Discontinuation
- 1999-06-30 EP EP99932772A patent/EP1091958A1/en not_active Withdrawn
- 1999-06-30 CZ CZ20004923A patent/CZ20004923A3/en unknown
- 1999-06-30 IL IL14038599A patent/IL140385A0/en unknown
- 1999-06-30 SK SK2024-2000A patent/SK20242000A3/en unknown
- 1999-06-30 BR BR9911679-0A patent/BR9911679A/en not_active Application Discontinuation
-
2000
- 2000-12-21 NO NO20006547A patent/NO20006547L/en not_active Application Discontinuation
-
2001
- 2001-01-02 ZA ZA200100020A patent/ZA200100020B/en unknown
- 2001-01-31 BG BG105204A patent/BG105204A/en unknown
- 2001-07-11 AU AU2002100370A patent/AU2002100370A4/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
NO20006547L (en) | 2001-02-12 |
HUP0103712A3 (en) | 2002-09-30 |
CZ20004923A3 (en) | 2001-08-15 |
ZA992899B (en) | 2000-03-29 |
JP2002519421A (en) | 2002-07-02 |
AU2002100370A4 (en) | 2002-06-06 |
EP1091958A1 (en) | 2001-04-18 |
HUP0103712A2 (en) | 2002-05-29 |
ZA200100020B (en) | 2002-03-25 |
BR9911679A (en) | 2002-01-29 |
BG105204A (en) | 2001-11-30 |
CA2336470A1 (en) | 2000-01-13 |
ID27766A (en) | 2001-04-26 |
SK20242000A3 (en) | 2001-07-10 |
CN1314906A (en) | 2001-09-26 |
KR20010053337A (en) | 2001-06-25 |
TR200100055T2 (en) | 2001-07-23 |
AU4903999A (en) | 2000-01-24 |
EA200100098A1 (en) | 2001-08-27 |
GB9814316D0 (en) | 1998-09-02 |
AP2000002017A0 (en) | 2000-12-31 |
NO20006547D0 (en) | 2000-12-21 |
IL140385A0 (en) | 2002-02-10 |
WO2000001692A1 (en) | 2000-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2336364B (en) | Paroxetine salt | |
IL137616A0 (en) | Variants of vegf-a | |
PL346544A1 (en) | Crystalline forms of eto2 | |
IL137684A0 (en) | Salts of paroxetine | |
PL345365A1 (en) | Salts of paroxetine | |
PL345999A1 (en) | Crystalline forms of osanetant | |
AU1788800A (en) | Derivative of paroxetine | |
PL345542A1 (en) | Novel salts of n-tert-butylhydroxylamine | |
IL138920A0 (en) | Paroxetine maleate | |
PL343095A1 (en) | Paroxetine compositions | |
PL349775A1 (en) | New morpholinobenzamide salts | |
GB9821628D0 (en) | Ionic salts | |
IL139596A0 (en) | Novel formulation containing paroxetine | |
HUP0101215A3 (en) | Chrystalline form of paroxetine | |
IL139081A0 (en) | Paroxetine ascorbate | |
PL344573A1 (en) | Novel formulation containing paroxetine | |
HU9904011D0 (en) | Novel salts of dipeptid derivatives | |
AU1398300A (en) | Amine salts of paroxetine | |
AU5294899A (en) | Paroxetine salts | |
SI1102747T1 (en) | Crystalline forms of osanetant | |
PL340294A1 (en) | Antipsychoic substituted derivatives of piperidine | |
TW392709U (en) | Structure of color-testing machine | |
TW354479U (en) | Improvement of earpick |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |